These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 2873091

  • 1. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L, Oepen G.
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [Abstract] [Full Text] [Related]

  • 2. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F, Dor E, Benoit M, Dupuis G, Serret S, Myquel M, Seddiki Y.
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Catatonia, malignant neuroleptic syndrome and myositis ossificans].
    Topka H, Buchkremer G.
    Nervenarzt; 1996 May; 67(5):413-7. PubMed ID: 9005354
    [Abstract] [Full Text] [Related]

  • 5. [Diagnostic difficulties and efficacy of electroconvulsive therapy in the treatment of lethal catatonia].
    Turczyński J.
    Psychiatr Pol; 1993 May; 27(5):535-43. PubMed ID: 7902992
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J.
    World J Biol Psychiatry; 2009 May; 10(1):70-3. PubMed ID: 19673089
    [Abstract] [Full Text] [Related]

  • 12. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G, Susman VL.
    J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837
    [Abstract] [Full Text] [Related]

  • 13. Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy.
    Suzuki K, Awata S, Nakagawa K, Takano T, Matsuoka H.
    Mov Disord; 2006 Jan; 21(1):123-4. PubMed ID: 16250024
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Catatonia, neuroleptics and brain damage--a case report.
    Chandran M, El-Shazly M.
    J Psychopharmacol; 2009 Mar; 23(2):223-6. PubMed ID: 18562406
    [Abstract] [Full Text] [Related]

  • 16. [Neuroleptic malignant syndrome and related conditions].
    Amore M, Montanari M.
    Minerva Psichiatr; 1992 Mar; 33(4):259-83. PubMed ID: 1363674
    [Abstract] [Full Text] [Related]

  • 17. Neuroleptic malignant syndrome and catatonia: one entity or two?
    Fink M.
    Biol Psychiatry; 1996 Jan 01; 39(1):1-4. PubMed ID: 8719118
    [No Abstract] [Full Text] [Related]

  • 18. ECT in the neuroleptic malignant syndrome: case report.
    Jessee SS, Anderson GF.
    J Clin Psychiatry; 1983 May 01; 44(5):186-8. PubMed ID: 6133848
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW.
    J Clin Psychopharmacol; 2010 Feb 01; 30(1):3-10. PubMed ID: 20075641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.